Revealing Shapes: Particle Morphology Hints Impurity Rejection Capability during API Crystallization

  • Presentation
  • September 24, 2020
About the author

Jochen Schöll
MSD Werthenstein BioPharma in Schachen Lucerne

About the presentation

The presentation discusses a common development challenge – the limited amount of API in pharma crystallization – and the 3 approaches that MSD laboratory has tested to make the best of it:

  • miniaturization
  • parallelization
  • data-rich experimentation

This presentation was first showcased during a webinar. You can watch a recording of that webinar in the Events & Webinars section here.

Download presentation